Publication:
MET exon 14 deletion (METex14): Finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of "40 years of wilderness" and into a clear path of regulatory approval

Issued Date

2015-01-01

Resource Type

Note

ISSN

22264477
22186751

DOI

10.3978/j.issn.2218-6751.2015.12.03

Other identifier(s)

2-s2.0-84960130558

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Translational Lung Cancer Research. Vol.4, No.6 (2015), 820-824

Suggested Citation

Thanyanan Reungwetwattana, Sai Hong Ignatius Ou MET exon 14 deletion (METex14): Finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of "40 years of wilderness" and into a clear path of regulatory approval. Translational Lung Cancer Research. Vol.4, No.6 (2015), 820-824. doi:10.3978/j.issn.2218-6751.2015.12.03 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/36805

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

MET exon 14 deletion (METex14): Finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of "40 years of wilderness" and into a clear path of regulatory approval

Author(s)

Thanyanan Reungwetwattana
 Sai Hong Ignatius Ou

Other Contributor(s)

Mahidol University
 UCI School of Medicine

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/123456789/36805

Collections

Scopus 2011-2015